auxora
Generic: zegocractin·Code: CM4620
auxora: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| CalciMedica, Inc. (CALC) | Phase 2 |
FDA Decisions
FDA_MeetingCompany plans an end-of-Phase 2 meeting with the FDA to inform Phase 3 design for Auxora based on CARPO trial results.(CALC)
Frequently asked questions
Who is developing auxora?
auxora is being developed by CalciMedica, Inc..
What is auxora's latest FDA decision?
The most recent tracked FDA decision for auxora is FDA_Meeting for Company plans an end-of-Phase 2 meeting with the FDA to inform Phase 3 design for Auxora based on CARPO trial results..
Get deeper analysis on auxora
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis